Addendum to: Nature Communications ; https://doi.org/10.1038/s41467-018-04994-z; published online 2 July 2018
Information relating to the in vivo treatments with A-196 and E-616452 was inadvertently omitted from the Methods section of this Article. In Fig. 6, Supplementary Fig. 7, as well as Supplementary Table 1, A-196 and E-616452 were used at a concentration of 25 mg/kg. A-196 and E-616452 were diluted in DMSO to a final concentration of 100 mM. Mice were treated with the inhibitors daily by oral gavage for 1 month.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lyu, G., Guan, Y., Zhang, C. et al. Addendum: TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging. Nat Commun 9, 4134 (2018). https://doi.org/10.1038/s41467-018-06710-3
Published:
DOI: https://doi.org/10.1038/s41467-018-06710-3
This article is cited by
-
Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues
Nature Biotechnology (2024)
-
SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome—the Myhre syndrome
GeroScience (2021)
-
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
Cancer Cell International (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.